Industry News

Home page

R&D Innovation Backed by Academic Expertise: Exploring the Core Value of Derui Medical's Simulation Technology Through a 3D Colon Model

In traditional medical device and drug development, animal testing often encounters the challenge of "predictive bias" due to species differences. This issue is particularly pronounced in colorectal cancer drug screening, where the physiological discrepancies between animal and human colons frequently lead to the failure of promising preclinical compounds during clinical trials. However, researchers at the University of California, Irvine, have developed a "3D in-vivo model of the human colon," offering a precise, personalized medicine approach—and providing an ethical, more accurate, and cost-effective alternative to conventional animal testing.

View All

The New Frontier in Cardiovascular Intervention: Market Opportunities and the Path to Breakthrough for Intracardiac Echocardiography (ICE)

ICE is increasingly being applied in areas such as cardiac electrophysiology therapy, minimally invasive treatment of valvular diseases, cardiac pacing, and intraoperative monitoring during congenital heart defect closure procedures. At the same time, it is playing an ever-more critical role in preoperative diagnosis of complex structural heart diseases. Currently, the most established application area remains arrhythmia management.

View All

Nanosecond pulse technology breaks new ground in atrial fibrillation treatment, with simulation tests driving innovation in medical devices—DeWei Medical empowers a new frontier in minimally invasive interventions.

Recently, the globally first nanosecond pulsed electric field ablation (nsPFA) system, NxPFA(®), independently developed by Shenzhen Maiwei Medical Technology Co., Ltd., has officially received approval from the National Medical Products Administration for market launch. This product marks the first medical device in China to utilize nanosecond-level pulse width and high-voltage pulsed electric fields for the treatment of atrial fibrillation. This milestone signifies a major technological breakthrough in China’s cardiovascular intervention therapy field.

View All

Medtronic partners with DASI Simulations to advance the future of TAVR through predictive modeling and personalized planning.

Medtronic plc, a leader in the medical technology sector, has formed a strategic partnership with DASI Simulations, a pioneer in AI-driven predictive modeling and digital twin technologies. This collaboration aims to broaden access to DASI’s cutting-edge technologies, ultimately enhancing outcomes for U.S. patients undergoing transcatheter aortic valve replacement (TAVR). By integrating DASI’s advanced AI-based predictive modeling and digital twin capabilities into the TAVR workflow, clinicians will gain independent, device-agnostic insights that can optimize patient care.

View All

Amid the rapid growth of the global endoscope market, DeWei Medical Endoscopy Models are supporting the R&D and testing of medical devices.

In the context of the global endoscopic device market, which continues to grow and sees ongoing technological innovation, minimally invasive interventional device companies are increasingly in need of high-quality R&D testing. Dewei Medical’s endoscope models—boasting high levels of realism, anatomical accuracy, versatility, and a wide range of advanced features—effectively address critical challenges faced by device manufacturers during R&D testing. By enhancing both development efficiency and product quality, these models empower companies to gain a competitive edge in today’s fiercely contested market, ultimately driving the sustainable and healthy growth of the endoscopic equipment industry.

View All

The Trio of Instrument Innovation: Building Blocks for Simulation Testing Under Miniaturization, Smart Integration, and Physiological Adaptation

View All

Revolutionizing Pacemaker Testing Paradigms with a Real-Time Closed-Loop Electrophysiological Heart Model: A Systemic Breakthrough from One-Way Validation to Dynamic Interaction

A research team from the University of Pennsylvania has enabled the testing of personalized treatment plans using patient-specific heart models. Doctors can now simulate how different pacing parameters would affect a particular patient in a virtual environment, allowing them to identify the optimal settings. "This technology provides "post-procedure insights" that are unavailable through conventional tests. By virtually recreating how CRT impacts cardiac electrophysiological-mechanical coupling, it accurately predicts real-world treatment responses." This is especially true for patients without left bundle branch block, where traditional prediction methods tend to be less reliable. In contrast, virtual cardiac resynchronization therapy based on patient-specific heart models has successfully improved predictive accuracy, demonstrating significant clinical potential.

View All

UDI Full Coverage Countdown: The Digital Revolution in Medical Device Regulation and Its Role in Protecting People's Livelihoods

On September 25, 2025, the Comprehensive Department of the National Medical Products Administration released two draft announcements seeking public input on the implementation of Unique Device Identification (UDI) for medical devices: "Announcement on Matters Relating to the Implementation of UDI for Specific Scenarios (Draft for Comments)" and "Announcement on Effectively Carrying Out UDI Implementation Work for Subsequent Product Categories (Draft for Comments)." This move aims to further align with relevant regulations and guidelines, while advancing the seamless integration of UDI across key sectors such as regulation, healthcare, and medical insurance.

View All

The CCI 10th Anniversary Conference Sparks a Surge in Medical Device Innovation, While Dewei Medical's Simulation Models Lay a Solid Foundation for R&D Validation.

View All

An Analysis of Hot Trends in Simulation Models for Medical Device R&D in 2025

View All

Medline's $50 billion IPO resumes, marking a significant milestone for the global medical device industry.

Medline, the world's fourth-largest medical device company, has restarted its IPO process—a move that goes beyond mere capital raising and is set to serve as a critical litmus test for global investor sentiment in the healthcare industry, as well as a key indicator of private equity exit strategies.

View All

Interpretation of the "Shanghai Action Plan for Promoting the Full-Chain Development of the High-End Medical Device Industry" and Its Impact on the Medical Device Sector

The "Action Plan" sets forth key 2027 targets centered around innovative products, industry leaders, and strategic regional development: achieving over 500 new Class III medical device registration certificates issued domestically, while encouraging companies to develop high-value-added, cutting-edge innovations; securing more than 100 overseas approvals for products, helping enterprises expand globally and compete on the world stage; fostering two international industry leaders each with an output value exceeding 10 billion yuan, positioning them as trailblazers in their fields; and establishing three high-end industrial clusters in Pudong, Minhang, and Jiading, promoting resource integration and collaborative growth.

View All

< 1 2 3 4 5 >

Request a quote

*Please keep your phone accessible—we'll reach out to you within 24 hours.

PARTNERSHIP

Partnership

Shenzhen Hospital of Fuwai Hospital, Chinese Academy of Medical Sciences

Beijing University of Aeronautics and Astronautics

China Academy of Medical Sciences Fuwai Hospital

Phone:+86 18192027578

Email: sales@deweimed.com

Address: Wangzuo Qujiang, 3269 Yanxiang Road, Yanta District, Xi'an City

Pre-sales Consultation

Request a quote

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Nickname | quit

Tel：8618192027578

Email：sales@deweimed.com

WhatsApp：8618182634037

COOKIES

COOKIES

Sorry，当前栏目暂无内容!

Sorry，The current column has no content!